High risk acute lymphoblastic leukemia in Denmark

References

• Clausen N, Scheibel E, Nyboe J. Prognostic factors for relapse free survival in childhood acute lymphoblastic leukemia. Scand J Haematol, (in press)
   Google Scholar
• Greaves M F, Janossy G, Peto J, Ray H. Immunologically defined subclasses of acute lymphoblastic leukemia in children: their relationship to presentation features and prognosis. Br J Haematol 1981; 48: 179–97
   PubMed Web of Science ®Google Scholar
• Gustafsson G, Kreuger A, Dohlwitz A. Acute lymphoblastic leukemia in Swedish children 1973–78. Acta Paediatr Scand 1981; 70: 609–14
   PubMed Web of Science ®Google Scholar
• Henze G, Langennann H-J, Ritter J, Schelling G, Riehm H. Treatment strategy for different risk groups in childhood acute lymphoblastic leukemia: a report from the BFM study group. Haematology and blood transfusion, vol 26:87–93. Modern trends in human leukemia. IV, Neth, Gallo, Graf, Mannweiler, Winkler. Springer-Verlag, Berlin Heidelberg 1981
   Google Scholar
• Jacquillat C, Weil M, Auclerc M F, et al. Prognosis and treatment of acute lymphoblasic leukemias. Study of 650 patients. Cancer Chemother Pharmacol 1978; 1: 113–22
   PubMedGoogle Scholar
• Mandelli F, Amadori S, Ceci A, et al. Long-term survival in childhood acute lymphocytic leukemia in Italy. Cancer 1981; 48: 2364–7
   PubMed Web of Science ®Google Scholar
• Miller D R. Prognostic factors in childhood leukemia. J Pediatr 1975; 87: 672–6
   PubMedGoogle Scholar
• Miller D R, Leikin S, Albo V, Sather H, Karon M, Hammond D. Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A Report from Children's Cancer Study Group. Cancer 1983; 51: 1041–9
   PubMed Web of Science ®Google Scholar
• Sallan S E, Ritz J, Pesando J, et al. Cell surface antigens. Prognostic implications in childhood acute lymphoblastic leukemia. Blood 1980; 55: 395–402
   PubMed Web of Science ®Google Scholar
• Chessells J M, Hardisty R M, Rapson N T, Greaves M F. Acute lymphoblastic leukemia in children: classification and prognosis. Lancet 1972; 2: 1307–9
   Google Scholar
• Sather H N, Miller D, Nesbit M, Heyn R, Hammond D. Differences in prognosis for boys and girls with acute lymphoblastic leukemia. Lancet 1981; 1: 739–43
   PubMed Web of Science ®Google Scholar
• Miller D R, Leikin S, Albo V, Sather H, Hammond D. Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukemia (ALL). Br J Haematol 1981; 48: 199–206
   PubMed Web of Science ®Google Scholar
• Clausen N, Scheibel E, Bro P, et al. Acute lymphoblastic leukemia in children in Denmark 1973–81. Ugeskr Laeg 1984; 146: 1028–32, Danish-English abstract
   PubMedGoogle Scholar
• Iversen T. Leukemia in infancy and childhood. A material of 570 Danish cases. Munksgaard, Copenhagen 1966
   Google Scholar
• Harrousseau J L, Tobelem G, Schaison G, et al. High risk acute lymphocytic leukemia. A study of 141 cases with initial white blood cell counts over 100,000/cu mm. Cancer 1980; 46: 1996–2003
   PubMedGoogle Scholar
• Dearth J C, Fountain K S, Smithson N A, Burgert E O, Gilcrist G S. Extreme leukeraic leukocytosis (blast crisis) in childhood. Mayo Clin Proc 1978; 53: 207–11
   PubMedGoogle Scholar
• Wald B R, Heisel M A, Ortega J. Frequency of early death in children with acute leukemia presenting with hyperleukocytosis. Cancer 1982; 50: 150–3
   PubMed Web of Science ®Google Scholar
• Harrousseau J L, Tobelem G, Schaison G, et al. Problemes d'urgence au cours du traitement initial des leucemies aigiies lymphoblastiques hyper-leucocytaires. Nouv Presse Med 1979; 8: 1827–30
   PubMedGoogle Scholar
• Misset J L, DeVassal F, Auclair H, et al. Improvement of results for poor risk childhood acute lymphoid leukemia 80% three year actuarial plateau of first remission (meeting abstract). Third International Symposium on Therapy of Acute Leukemias. Dec., 10–141982. University of Rome, RomeItaly, 290
   Google Scholar
• Moe P J, Seip M, Finne P H, Kolmannskog S. The Norwegian methotrexate study in childhood acute lymphocytic leukemia. Meeting abstract. Third International Symposium on Therapy of Acute Leukemias. Dec., 10–141982. University of Rome, RomeItaly, 346
   Google Scholar
• Nesbit M E, Sather H N, Ortega J, et al. Effect of isolated central nervous system leukemia on bone marrow remission and survival in childhood acute lymphoblastic leukemia. Lancet 1981; 1: 1386–9
   PubMed Web of Science ®Google Scholar
• Muriel F S, Svarch E, Pavlovsky S, et al. Comparison of central nervous system prophylaxis with cranial radiation and intrathecal methotrexate versus intra-thecal methotrexate aline in acute lymphoblastic leukemia. Blood 1983; 62: 241–50
   PubMedGoogle Scholar
• Rohlfing M B, Barton T K, Bigner S H, Johnston W W. Contamination of cerebrospinal fluid specimens with hematogenous blasts in patients with leukemia. Acta Cytol 1981; 25: 611–15
   PubMedGoogle Scholar